<SEC-DOCUMENT>0000950103-25-012450.txt : 20250929
<SEC-HEADER>0000950103-25-012450.hdr.sgml : 20250929
<ACCEPTANCE-DATETIME>20250929165604
ACCESSION NUMBER:		0000950103-25-012450
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20250929
DATE AS OF CHANGE:		20250929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251357010

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251357011

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp235089_424b2-us2512330d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 65%">
    <P STYLE="color: #888888; font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 18.6pt 0pt 4.2pt">Citigroup Global Markets Holdings Inc.</P></TD>
    <TD STYLE="white-space: nowrap; width: 35%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0; text-align: right; color: gray"><B>September 25, 2025</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0; text-align: right; color: gray"><B>Medium-Term Senior Notes,
    Series N</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0; text-align: right; color: gray"><B>Pricing Supplement No.
    2025-USNCH28442</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0; text-align: right; color: gray"><B>Filed Pursuant to Rule
    424(b)(2)</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0; text-align: right; color: gray"><FONT STYLE="background-color: white"><B>Registration
    Statement Nos.&nbsp;&nbsp;333-270327 and 333-270327-01</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); margin: 0pt 0">Autocallable Barrier Securities Linked to the Worst
Performing of the EURO STOXX 50<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP> Index Due September 28, 2028</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 2%"><FONT STYLE="color: #59AE40">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc.&nbsp;&nbsp;Unlike conventional debt securities, the securities do not pay interest, do not guarantee the
repayment of principal at maturity and are subject to potential automatic early redemption on a periodic basis on the terms described
below. Your return on the securities will depend solely on the performance of the <B>worst performing</B> of the underlyings specified
below.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt; color: #59AE40">&squarf;</FONT></TD><TD>The securities offer the potential for automatic early redemption at a premium following the first valuation date (other than the
final valuation date) on which the closing value of the worst performing underlying on that valuation date is greater than or equal to
its then-applicable autocall barrier value. If the securities are not automatically redeemed prior to maturity, the securities will provide
for repayment of the stated principal amount plus a premium at maturity if the final underlying value of the worst performing underlying
on the final valuation date is greater than or equal to its final barrier value. <B>However, if the securities are not automatically redeemed
prior to maturity and the final underlying value of the worst performing underlying on the final valuation date is less than its final
barrier value, you will lose 1% of the stated principal amount of your securities for every 1% by which its final underlying value is
less than its initial underlying value.&nbsp;&nbsp;You may lose a significant portion, and up to all, of your investment.</B>&nbsp;&nbsp;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 2%"><FONT STYLE="color: #59AE40">&squarf;</FONT></TD><TD>You will be subject to risks associated with <U>each</U> of the underlyings and will be negatively affected by adverse movements in
<U>any one</U> of the underlyings. Although you will have downside exposure to the worst performing underlying on the final valuation
date, you will not receive dividends with respect to any underlying or participate in any appreciation of any underlying.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 2%"><FONT STYLE="color: #59AE40">&squarf;</FONT></TD><TD>Investors in the securities must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of
not receiving any payments due under the securities if we and Citigroup Inc. default on our obligations. <B>All payments on the securities
are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE40">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Issuer:</B></FONT></TD>
    <TD STYLE="width: 80%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E5F0E0">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 20%; border-right: Black 1pt solid; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlyings:</B></FONT></TD>
    <TD STYLE="width: 36%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 22%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Initial underlying value*</B></FONT></TD>
    <TD STYLE="width: 22%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE43"><B>Final barrier value**</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; layout-grid-mode: char">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">5,444.89</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">4,628.157</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; layout-grid-mode: char">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">6,604.72</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">5,614.012</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 80%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.75pt 0pt 0">* For each underlying, its closing value on the pricing
    date</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">** For each underlying, 85% of its initial underlying value</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E5F0E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Stated principal amount: </B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Pricing date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">September 25, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E5F0E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Issue date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">September 30, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Maturity date: </B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Unless earlier redeemed, September 28, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E5F0E0">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Automatic early redemption:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">If, on any valuation date prior to the final valuation date, the closing value of the worst performing underlying on that valuation date is greater than or equal to its then-applicable autocall barrier value, the securities will be automatically redeemed on the third business day immediately following that valuation date for an amount in cash per security equal to $1,000 <I>plus</I> the premium applicable to that valuation date.&nbsp;&nbsp;If the securities are automatically redeemed following any valuation date prior to the final valuation date, they will cease to be outstanding and you will not receive the premium applicable to any later valuation date. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Payment at maturity:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
    you will receive at maturity, for each security you then hold, an amount in cash equal to:</P>
    <P STYLE="font: 10pt Wingdings; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt">&sect;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.3in">If the final underlying value of the worst performing underlying
    on the final valuation date is <B>greater than or equal to</B> its final barrier value: $1,000 + the premium applicable to the final valuation
    date</P>
    <P STYLE="font: 10pt Wingdings; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt">&sect;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.3in">If the final underlying value of the worst performing underlying
    on the final valuation date is <B>less than</B> its final barrier value:<BR>
    $1,000 + ($1,000 &times; the underlying return of the worst performing underlying on the final valuation date)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not automatically redeemed prior to maturity
    and the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier value, your
    payment at maturity will be less, and possibly significantly less, than the stated principal amount of your securities. You should not
    invest in the securities unless you are willing and able to bear the risk of losing a significant portion, and up to all, of your investment.&nbsp;&nbsp;
    </B></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E5F0E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Listing:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">17333MB77 / US17333MB777</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E5F0E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underwriter:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;CGMI&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 30%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Issue price</B></FONT><B><FONT STYLE="font-size: 10pt; color: #59AE40"><SUP>(1)</SUP></FONT></B></TD>
    <TD STYLE="width: 23%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underwriting fee</B></FONT><B><FONT STYLE="font-size: 10pt; color: #59AE40"><SUP>(2)</SUP></FONT></B></TD>
    <TD STYLE="width: 27%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Proceeds to issuer</B></FONT><B><FONT STYLE="font-size: 10pt; color: #59AE40"><SUP>(3)</SUP></FONT></B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E5F0E0">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$21.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$979.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$7,358,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$154,518.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$7,203,482.00</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><I>(Key Terms continued on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) On the date of this pricing supplement, the estimated value of the
securities is $970.40 per security, which is less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s
proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates,
nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time
after issuance. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) CGMI will receive an underwriting fee of up to $21.00 for each security
sold in this offering. The total underwriting fee and proceeds to issuer in the table above give effect to the actual total underwriting
fee. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a variable selling concession of up to $20.00
for each security they sell and a structuring fee of up to $1.00 for each security they sell. For more information on the distribution
of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting fee,
CGMI and its affiliates may profit from hedging activity related to this offering, even if the value of the securities declines. See &ldquo;Use
of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(3) The per security proceeds to issuer indicated above represent the
minimum per security proceeds to issuer for any security, assuming the maximum per security underwriting fee. As noted above, the underwriting
fee is variable.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-8.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, underlying supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks
below:</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm" STYLE="color: rgb(89,174,64); text-decoration: underline"><FONT STYLE="color: #59AE43"><B>Product Supplement No. EA-02-10 dated March 7, 2023</B></FONT></A></TD>
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: rgb(89,174,64); text-decoration: underline"><FONT STYLE="color: #59AE43"><B>Underlying Supplement No. 11 dated March 7, 2023</B></FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE43"><B><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,64); text-decoration: underline">Prospectus Supplement and Prospectus each dated March 7, 2023</A></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE40">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="14" STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Valuation dates and premiums:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">The valuation dates and the premium applicable to each valuation date are set forth below.&nbsp;&nbsp;<B>The premium may be significantly less than the appreciation of any underlying from the pricing date to the applicable valuation date.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Valuation date*</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Premium</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">March 25, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">4.7750% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">June 25, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">7.1625% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">September 28, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">9.5500% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">December 28, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">11.9375% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">March 25, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">14.3250% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">June 25, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">16.7125% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">September 27, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">19.1000% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">December 27, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">21.4875% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">March 27, 2028</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">23.8750% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">June 26, 2028</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">26.2625% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font-size: 12pt"><FONT STYLE="font-size: 10pt">September 25, 2028 (the &ldquo;final valuation date&rdquo;)</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">28.6500% of the stated principal amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">*Each valuation date is subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD ROWSPAN="11" STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Autocall barrier values:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, the autocall barrier value applicable to each valuation date (other than the final valuation date) is the percentage of the initial underlying value of such underlying indicated below.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">March 25, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 100.00% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">June 25, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 98.50% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">September 28, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 97.00% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">December 28, 2026</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 95.50% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">March 25, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 94.00% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">June 25, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 92.50% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">September 27, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 91.00% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">December 27, 2027</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 89.50% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">March 27, 2028</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 88.00% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="padding-left: 21.7pt; font-size: 12pt"><FONT STYLE="font-size: 10pt">June 26, 2028</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, 86.50% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlying return: </B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying on any valuation date, (i) its closing value on that valuation date <I>minus </I>its initial underlying value, <I>divided by</I> (ii) its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Worst performing underlying:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For any valuation date, the underlying with the lowest underlying return determined as of that valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Final underlying value:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">For each underlying, its closing value on the final valuation date</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Additional Information</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the securities are set forth in the accompanying product
supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying product supplement,
prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement.&nbsp;&nbsp;For example,
the accompanying product supplement contains important information about how the closing value of each underlying will be determined and
about adjustments that may be made to the terms of the securities upon the occurrence of market disruption events and other specified
events with respect to each underlying.&nbsp;&nbsp;The accompanying underlying supplement contains information about each underlying that
is not repeated in this pricing supplement.&nbsp;&nbsp;It is important that you read the accompanying product supplement, underlying supplement,
prospectus supplement and prospectus together with this pricing supplement in connection with your investment in the securities.&nbsp;&nbsp;Certain
terms used but not defined in this pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Hypothetical Payment
Upon Automatic Early Redemption </FONT></P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following table illustrates how the amount payable per security
upon automatic early redemption will be calculated if the closing value of the worst performing underlying on any valuation date prior
to the final valuation date is greater than or equal to its then-applicable autocall barrier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: left; vertical-align: bottom; width: 32%; font-size: 10pt"><B>If the closing value of the worst performing underlying on the following valuation date. . .</B></TD>
    <TD STYLE="text-align: left; width: 1%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom; width: 33%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&hellip;is greater than or equal to the following autocall barrier
level&hellip;&nbsp;</B></P></TD>
    <TD STYLE="text-align: left; width: 1%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom; width: 33%; font-size: 10pt"><B>. . . then you will receive the following payment per $1,000 security upon automatic early redemption:</B></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">1<SUP>st</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">100.00% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $47.750 <BR>
= $1,047.750</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2<SUP>nd</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">98.50% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $71.625 <BR>
= $1,071.625</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">3<SUP>rd</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">97.00% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $95.500 <BR>
= $1,095.500</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">4<SUP>th</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">95.50% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $119.375 <BR>
= $1,119.375</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5<SUP>th</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">94.00% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $143.250 <BR>
= $1,143.250</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">6<SUP>th</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">92.50% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $167.125 <BR>
= $1,167.125</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">7<SUP>th</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">91.00% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $191.000 <BR>
= $1,191.000</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">8<SUP>th</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">89.50% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $214.875 <BR>
= $1,214.875</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">9<SUP>th</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">88.00% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $238.750 <BR>
= $1,238.750</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10<SUP>th</SUP> valuation date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">86.50% of the initial underlying value</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $262.625 = $1,262.625</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If, on any valuation date prior to the final valuation date, the
closing value of any underlying is less than its then-applicable autocall barrier value, you will not receive the premium indicated above
following that valuation date.&nbsp;&nbsp;In order to receive the premium indicated above, the closing value of <I>each</I> underlying
on the applicable valuation date must be greater than or equal to its then-applicable autocall barrier value.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40"><FONT STYLE="background-color: white">Payment at Maturity
Diagram&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The diagram below illustrates the payment at maturity of the securities,
assuming the securities have not previously been automatically redeemed, for a range of hypothetical underlying returns of the worst performing
underlying on the final valuation date.&nbsp;&nbsp;Your payment at maturity (if the securities are not earlier automatically redeemed)
will be determined based solely on the performance of the worst performing underlying on the final valuation date.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive any dividends with respect
to the underlyings. The diagram and examples below do not show any effect of lost dividend yield over the term of the securities.</B>
See &ldquo;Summary Risk Factors&mdash;You will not receive dividends or have any other rights with respect to the underlyings&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 100%; border: Black 1pt solid; text-align: center; font-size: 14pt; color: #296DC1"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Payment at Maturity</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.gif" ALT="" STYLE="height: 353px; width: 559px"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Wingdings; color: #59AE43">n</FONT>
    The Securities&nbsp;&nbsp;&nbsp; <FONT STYLE="font-family: Wingdings">n</FONT> The Worst Performing Underlying on the Final Valuation
    Date</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40"><FONT STYLE="font-weight: normal">Hypothetical Examples
of the Payment at Maturity</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are intended to illustrate how, if the securities
are not automatically redeemed prior to maturity, your payment at maturity will depend on the final underlying value of the worst performing
underlying on the final valuation date. Your actual payment at maturity per security, if the securities are not automatically redeemed
prior to maturity, will depend on the actual final underlying value of the worst performing underlying on the final valuation date. The
examples are solely for illustrative purposes, do not show all possible outcomes and are not a prediction of any payment that may be made
on the securities.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying values or final barrier values of the underlyings. For the actual initial underlying value
and final barrier value of each underlying, see the cover page of this pricing supplement. We have used these hypothetical values, rather
than the actual values, to simplify the calculations and aid understanding of how the securities work. However, you should understand
that the actual payments on the securities will be calculated based on the actual initial underlying value and final barrier value of
each underlying, and not the hypothetical values indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 32%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Hypothetical initial underlying value</B></FONT></TD>
    <TD STYLE="width: 36%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Hypothetical final b</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #59AE40">arrier <FONT STYLE="font-size: 10pt">value</FONT></FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 3.8pt; font-size: 12pt; text-align: center; text-indent: -0.35pt"><FONT STYLE="font-size: 10pt">85.00 (85.00% of its hypothetical <BR>
initial underlying value)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 3.8pt; font-size: 12pt; text-align: center; text-indent: -0.35pt"><FONT STYLE="font-size: 10pt">85.00 (85.00% of its hypothetical <BR>
initial underlying value)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1&mdash;Upside Scenario A.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; border: #59AE43 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 32%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 36%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt">EURO STOXX 50<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">130.00</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">30.00%</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">98.00</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">-2.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, the S&amp;P 500<SUP>&reg;</SUP> Index has the lowest
underlying return and is, therefore, the worst performing underlying on the final valuation date.&nbsp;&nbsp;Because the final underlying
value of the worst performing underlying on the final valuation date is greater than its final barrier value, you would be repaid the
stated principal amount of your securities at maturity <I>plus</I> the premium applicable to the final valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the premium applicable to
the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $286.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,286.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2&mdash;Upside Scenario B.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; border: #59AE43 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 32%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 36%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt">EURO STOXX 50<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">160.00</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">60.00%</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center; font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Index</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">165.00</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center; font-size: 10pt">65.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, the EURO STOXX 50<SUP>&reg;</SUP> Index has the lowest
underlying return and is, therefore, the worst performing underlying on the final valuation date.&nbsp;&nbsp;Because the final underlying
value of the worst performing underlying on the final valuation date is greater than its final barrier value, you would be repaid the
stated principal amount of your securities at maturity <I>plus</I> the premium applicable to the final valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the premium applicable to
the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $286.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,286.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, an investment in the securities would underperform
a hypothetical alternative investment providing 1-to-1 exposure to the appreciation of the worst performing underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3&mdash;Downside Scenario.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border: Black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="color: #59AE40"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 30%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="color: #59AE40"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 38%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="color: #59AE40"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt">30.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt">-70.00%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt; layout-grid-mode: char"><FONT STYLE="font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt">105.00</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt">5.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, the EURO STOXX 50<SUP>&reg;</SUP> Index has the lowest
underlying return and is, therefore, the worst performing underlying on the final valuation date.&nbsp;&nbsp;Because the final underlying
value of the worst performing underlying on the final valuation date is less than its final barrier value, you would receive a payment
at maturity per security that is significantly less than the stated principal amount, calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + ($1,000 &times; the underlying
return of the worst performing underlying on the final valuation date)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; -70.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + -$700.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $300.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the worst performing underlying on the final valuation
date has depreciated from its initial underlying value to its final underlying value. As a result, your total return at maturity in this
scenario would be negative and would reflect 1-to-1 exposure to the negative performance of the worst performing underlying on the final
valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Summary Risk Factors</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities.&nbsp;&nbsp;The securities are subject to all of the risks associated with an investment in our conventional
debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the
securities, and are also subject to risks associated with each underlying.&nbsp;&nbsp;Accordingly, the securities are suitable only for
investors who are capable of understanding the complexities and risks of the securities.&nbsp;&nbsp;You should consult your own financial,
tax and legal advisors as to the risks of an investment in the securities and the suitability of the securities in light of your particular
circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks relating to an investment
in the securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying
product supplement.&nbsp;&nbsp;You should also carefully read the risk factors included in the accompanying prospectus supplement and
in the documents incorporated by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report
on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances.&nbsp;&nbsp;If the securities are not automatically
redeemed prior to maturity, your payment at maturity will depend on the final underlying value of the worst performing underlying on the
final valuation date.&nbsp;&nbsp;If the final underlying value of the worst performing underlying on the final valuation date is less
than its final barrier value, you will lose 1% of the stated principal amount of the securities for every 1% by which the worst performing
underlying on the final valuation date has declined from its initial underlying value.&nbsp;&nbsp;There is no minimum payment at maturity
on the securities, and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>Your potential return on the securities is limited.</B>&nbsp;&nbsp;Your potential return on the securities is limited to the applicable
premium payable upon automatic early redemption or at maturity, as described on the cover page of this pricing supplement. If the closing
value of the worst performing underlying on one of the valuation dates is greater than or equal to its then-applicable autocall barrier
value or final barrier value, you will be repaid the stated principal amount of your securities and will receive the fixed premium applicable
to that valuation date, regardless of how significantly the closing value of the worst performing underlying on that valuation date may
exceed its initial underlying value.&nbsp;&nbsp;Accordingly, any premium may result in a return on the securities that is significantly
less than the return you could have achieved on a direct investment in any or all of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities do not pay interest.</B> You should not invest in the securities if you seek current income during the term of the
securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities are subject to heightened risk because they have multiple underlyings.&nbsp;&nbsp;</B>The securities are more risky
than similar investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any
one underlying will perform poorly, adversely affecting your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs
poorly.</B>&nbsp;&nbsp;You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will
be negatively affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings
would be better than the performance of the worst performing underlying alone.&nbsp;&nbsp;Instead, you are subject to the full risks of
whichever of the underlyings is the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>You will not benefit in any way from the performance of any better performing underlying.&nbsp;&nbsp;</B>The return on the securities
depends solely on the performance of the worst performing underlying, and you will not benefit in any way from the performance of any
better performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings.</B>&nbsp;&nbsp;It is preferable from your perspective
for the underlyings to be correlated with each other, in the sense that their closing values tend to increase or decrease at similar times
and by similar magnitudes.&nbsp;&nbsp;By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship.&nbsp;&nbsp;The
less correlated the underlyings, the more likely it is that any one of the underlyings will perform poorly over the term of the securities.
All that is necessary for the securities to perform poorly is for one of the underlyings to perform poorly.&nbsp;&nbsp;It is impossible
to predict what the relationship between the underlyings will be over the term of the securities.&nbsp;&nbsp;The underlyings differ in
significant ways and, therefore, may not be correlated with each other.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities may be automatically redeemed prior to maturity, limiting the term of the securities.</B>&nbsp;&nbsp;If the closing
value of the worst performing underlying on any valuation date (other than the final valuation date) is greater than or equal to its then-applicable
autocall barrier value, the securities will be automatically redeemed.&nbsp;&nbsp;If the securities are automatically redeemed following
any valuation date prior to the final valuation date, they will cease to be outstanding and you will not receive the premium applicable
to any later valuation date. Moreover, you may not be able to reinvest your funds in another investment that provides a similar yield
with a similar level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities offer downside exposure to the worst performing underlying, but no upside exposure to any underlying.</B> You will
not participate in any appreciation in the value of any underlying over the term of the securities. Consequently, your return on the securities
will be limited to the applicable premium payable upon an automatic early redemption or at maturity and may be significantly less than
the return on any underlying over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>You will not receive dividends or have any other rights with respect to the underlyings.&nbsp;&nbsp;</B>You will not receive any
dividends with respect to the underlyings.&nbsp;&nbsp;This lost dividend yield may be significant over the term of the securities.&nbsp;&nbsp;The
payment scenarios</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">described in this pricing supplement do
not show any effect of such lost dividend yield over the term of the securities.&nbsp;&nbsp;In addition, you will not have voting rights
or any other rights with respect to the underlyings or the stocks included in the underlyings.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The performance of the securities will depend on the closing values of the underlyings solely on the valuation dates, which makes
the securities particularly sensitive to volatility in the closing values of the underlyings on or near the valuation dates.</B>&nbsp;&nbsp;Whether
the securities will be automatically redeemed prior to maturity will depend on the closing values of the underlyings solely on the valuation
dates (other than the final valuation date), regardless of the closing values of the underlyings on other days during the term of the
securities. If the securities are not automatically redeemed prior to maturity, what you receive at maturity will depend solely on the
closing value of the worst performing underlying on the final valuation date, and not on any other day during the term of the securities.
Because the performance of the securities depends on the closing values of the underlyings on a limited number of dates, the securities
will be particularly sensitive to volatility in the closing values of the underlyings on or near the valuation dates. You should understand
that the closing value of each underlying has historically been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.&nbsp;&nbsp;</B>If we
default on our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything
owed to you under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&nbsp;&nbsp;</B>The
securities will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities.&nbsp;&nbsp;CGMI
currently intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on
a daily basis.&nbsp;&nbsp;Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion,
taking into account prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities
can be sold at that price, or at all.&nbsp;&nbsp;CGMI may suspend or terminate making a market and providing indicative bid prices without
notice, at any time and for any reason.&nbsp;&nbsp;If CGMI suspends or terminates making a market, there may be no secondary market at
all for the securities because it is likely that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity.&nbsp;&nbsp;Accordingly,
an investor must be prepared to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price</B>.&nbsp;&nbsp;The difference is attributable to certain costs associated with selling, structuring
and hedging the securities that are included in the issue price.&nbsp;&nbsp;These costs include (i) any selling concessions or other fees
paid in connection with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with
the offering of the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates
in connection with hedging our obligations under the securities.&nbsp;&nbsp;These costs adversely affect the economic terms of the securities
because, if they were lower, the economic terms of the securities would be more favorable to you.&nbsp;&nbsp;The economic terms of the
securities are also likely to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to
price the securities.&nbsp;&nbsp;See &ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary
market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.&nbsp;&nbsp;</B>CGMI
derived the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models.&nbsp;&nbsp;In
doing so, it may have made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between,
the closing values of the underlyings, dividend yields on the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ
from your or others&rsquo; views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours.&nbsp;&nbsp;Both
the models and the inputs to the models may prove to be wrong and therefore not an accurate reflection of the value of the securities.&nbsp;&nbsp;Moreover,
the estimated value of the securities set forth on the cover page of this pricing supplement may differ from the value that we or our
affiliates may determine for the securities for other purposes, including for accounting purposes.&nbsp;&nbsp;You should not invest in
the securities because of the estimated value of the securities.&nbsp;&nbsp;Instead, you should be willing to hold the securities to maturity
irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #296DC1; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><FONT STYLE="color: black"><B>The estimated value of the securities would be lower if it were calculated based on our secondary market
rate.&nbsp;&nbsp;</B>The estimated value of the securities included in this pricing supplement is calculated based on our internal funding
rate, which is the rate at which we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally
lower than our secondary market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of
any purchases of the securities from you in the secondary market.&nbsp;&nbsp;If the estimated value included in this pricing supplement
were based on our secondary market rate, rather than our internal funding rate, it would likely be lower.&nbsp;&nbsp;We determine our
internal funding rate based on factors such as the costs associated with the securities, which are generally higher than the costs associated
with conventional debt securities, and our liquidity needs and preferences.&nbsp;&nbsp;Our internal funding rate is not an interest rate
that is payable on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion.&nbsp;&nbsp;As a result, our secondary market rate is not a market-determined measure
of our creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted
for discretionary factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B>&nbsp;&nbsp;Any such secondary market price will fluctuate over the term of
the securities based on the market and other factors described in the next risk factor.&nbsp;&nbsp;Moreover, unlike the estimated value
included in this pricing supplement, any value of the securities determined for purposes of a secondary market transaction will be based
on our secondary market rate, which will likely result in a lower value for the securities than if our internal funding rate were</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">used.&nbsp;&nbsp;In addition, any secondary market price
for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the securities
to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.&nbsp;&nbsp;As a
result, it is likely that any secondary market price for the securities will be less than the issue price.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors. </B>The value of your securities
prior to maturity will fluctuate based on the closing values of the underlyings, the volatility of, and correlation between, the closing
values of the underlyings, dividend yields on the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup
Inc.&rsquo;s creditworthiness, as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating
to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based
on many unpredictable factors&rdquo; in the accompanying product supplement.&nbsp;&nbsp;Changes in the closing values of the underlyings
may not result in a comparable change in the value of your securities.&nbsp;&nbsp;You should understand that the value of your securities
at any time prior to maturity may be significantly less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.&nbsp;&nbsp;</B>The amount of this temporary
upward adjustment will steadily decline to zero over the temporary adjustment period.&nbsp;&nbsp;See &ldquo;Valuation of the Securities&rdquo;
in this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The EURO STOXX 50<SUP>&reg;</SUP> Index is subject to risks associated with non-U.S. markets.</B> Investments linked to the value
of non-U.S. stocks involve risks associated with the securities markets in those countries, including risks of volatility in those markets,
governmental intervention in those markets and cross-shareholdings in companies in certain countries. Also, there is generally less publicly
available information about companies in some of these jurisdictions than about U.S. companies that are subject to the reporting requirements
of the SEC. Further, non-U.S. companies are generally subject to accounting, auditing and financial reporting standards and requirements
and securities trading rules that are different from those applicable to U.S. reporting companies. The prices of securities in foreign
markets may be affected by political, economic, financial and social factors in those countries, or global regions, including changes
in government, economic and fiscal policies and currency exchange laws. Moreover, the economies in such countries may differ favorably
or unfavorably from the economy of the United States in such respects as growth of gross national product, rate of inflation, capital
reinvestment, resources and self-sufficiency.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The performance of the EURO STOXX 50<SUP>&reg;</SUP> Index will not be adjusted for changes in the exchange rate between the euro
and the U.S. dollar.</B> The EURO STOXX 50<SUP>&reg;</SUP> Index is composed of stocks traded in euro, the value of which may be subject
to a high degree of fluctuation relative to the U.S. dollar. However, the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index and the
value of your securities will not be adjusted for exchange rate fluctuations. If the euro appreciates relative to the U.S. dollar over
the term of the securities, the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index as measured for purposes of the securities will
be less than it would have been if it offered exposure to that appreciation in addition to the change in the prices of the stocks included
in the EURO STOXX 50<SUP>&reg;</SUP> Index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of any underlying. </B>The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlyings is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlyings or in
instruments related to the underlyings, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the closing values of the underlyings in a way that
negatively affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The closing value of an underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>&nbsp;&nbsp;We
have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions in the underlyings
or in financial instruments related to the underlyings and may adjust such positions during the term of the securities.&nbsp;&nbsp;Our
affiliates also take positions in the underlyings or in financial instruments related to the underlyings on a regular basis (taking long
or short positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of
customers. These activities could affect the closing values of the underlyings in a way that negatively affects the value of and your
return on the securities. They could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies.&nbsp;&nbsp;These activities include extending loans, making
and facilitating investments, underwriting securities offerings and providing advisory services.&nbsp;&nbsp;These activities could involve
or affect the underlyings in a way that negatively affects the value of and your return on the securities. They could also result in substantial
returns for us or our affiliates while the value of the securities declines.&nbsp;&nbsp;In addition, in the course of this business, we
or our affiliates may acquire non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B>&nbsp;&nbsp;If
certain events occur during the term of the securities, such as market disruption events and other events with respect to an underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.&nbsp;&nbsp;In
making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities.&nbsp;&nbsp;See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The
calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying
product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>Changes that affect the underlyings may affect the value of your securities.</B>&nbsp;&nbsp;The sponsors of the underlyings may
at any time make methodological changes or other changes in the manner in which they operate that could affect the values of the</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">underlyings.&nbsp;&nbsp;We are not affiliated with any such
underlying sponsor and, accordingly, we have no control over any changes any such sponsor may make.&nbsp;&nbsp;Such changes could adversely
affect the performance of the underlyings and the value of and your return on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in th<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">e securities ar</FONT>e
unclear.&nbsp;&nbsp;</B>There is no direct legal authority regarding the proper U.S. federal tax treatment of the securities, and we do
not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;).&nbsp;&nbsp;Consequently, significant aspects of
the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of the securities as prepaid
forward contracts.&nbsp;&nbsp;If the IRS were successful in asserting an alternative treatment of the securities, the tax consequences
of the ownership and disposition of the securities might be materially and adversely affected.&nbsp;&nbsp;Moreover, future legislation,
Treasury regulations or IRS guidance could adversely affect the U.S. federal tax treatment of the securities, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">If you are a non-U.S. investor, you should review the discussion
of withholding tax issues in &ldquo;United States Federal Tax Considerations&mdash;Non-U.S. Holders&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">You should read carefully the discussion under &ldquo;United
States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement
and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement.&nbsp;&nbsp;You should also consult your tax adviser
regarding the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under the laws of
any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information About the EURO STOXX 50<SUP>&reg;</SUP>
Index</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The EURO STOXX 50<SUP>&reg;</SUP> Index is composed of 50 component
stocks of market sector leaders from within the EURO STOXX<SUP>&reg;</SUP> Supersector indices, which represent the Eurozone portion of
the STOXX Europe 600<SUP>&reg;</SUP> Supersector indices. The STOXX Europe 600<SUP>&reg;</SUP> Supersector indices contain the 600 largest
stocks traded on the major exchanges of certain European countries. The EURO STOXX 50<SUP>&reg;</SUP> Index is calculated and maintained
by STOXX Limited.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;
The STOXX Benchmark Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the EURO STOXX 50<SUP>&reg;</SUP>
Index from publicly available information and have not independently verified any information regarding the EURO STOXX 50<SUP>&reg;</SUP>
Index. This pricing supplement relates only to the securities and not to the EURO STOXX 50<SUP>&reg;</SUP> Index. We make no representation
as to the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the EURO STOXX 50<SUP>&reg;</SUP> Index is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the EURO STOXX 50<SUP>&reg;</SUP> Index on September
25, 2025 was 5,444.89.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the EURO STOXX 50<SUP>&reg;</SUP>
Index for each day such value was available from January 2, 2015 to September 25, 2025. We obtained the closing values from Bloomberg
L.P., without independent verification. You should not take the historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 30%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: Black 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>EURO STOXX 50<SUP>&reg;</SUP> Index &ndash; Historical Closing Values<BR>
January 2, 2015 to September 25, 2025</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 10pt; text-align: center"><IMG SRC="image_002.gif" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information About the S&amp;P 500<SUP>&reg;</SUP> Index</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The S&amp;P 500<SUP>&reg;</SUP>
Index consists of the common stocks of 500 issuers selected to provide a performance benchmark for the large capitalization segment of
the U.S. equity markets. It is calculated and maintained by S&amp;P Dow Jones Indices LLC.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Please refer to the section &ldquo;Equity
Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; in the accompanying underlying supplement for additional information.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">We have derived all information
regarding the S&amp;P 500<SUP>&reg;</SUP> Index from publicly available information and have not independently verified any information
regarding the S&amp;P 500<SUP>&reg;</SUP> Index. This pricing supplement relates only to the securities and not to the S&amp;P 500<SUP>&reg;</SUP>
Index. We make no representation as to the performance of the S&amp;P 500<SUP>&reg;</SUP> Index over the term of the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The securities represent obligations
of Citigroup Global Markets Holdings Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the S&amp;P 500<SUP>&reg;</SUP> Index is
not involved in any way in this offering and has no obligation relating to the securities or to holders of the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The closing value of the S&amp;P
500<SUP>&reg; </SUP>Index on September 25, 2025 was 6,604.72.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The graph below shows the closing
value of the S&amp;P 500<SUP>&reg;</SUP> Index for each day such value was available from January 2, 2015 to September 25, 2025. We obtained
the closing values from Bloomberg L.P., without independent verification. You should not take the historical closing values as an indication
of future performance.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 30%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: Black 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>S&amp;P 500<SUP>&reg;</SUP> Index &ndash; Historical Closing Values<BR>
January 2, 2015 to September 25, 2025</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><IMG SRC="image_003.gif" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">United States Federal Tax Considerations</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which
is based on current market conditions, a security should be treated as a prepaid forward contract for U.S. federal income tax purposes.&nbsp;&nbsp;By
purchasing a security, you agree (in the absence of an administrative determination or judicial ruling to the contrary) to this treatment.
There is uncertainty regarding this treatment, and the IRS or a court might not agree with it.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>You should not recognize taxable income over the term of the securities prior to maturity, other than pursuant to a sale or exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the security.&nbsp;&nbsp;Such gain or loss should be long-term capital gain or loss
if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders</B>. Subject to the discussions below and in &ldquo;United
States Federal Tax Considerations&rdquo; in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying
product supplement) of the securities, you generally should not be subject to U.S. federal withholding or income tax in respect of any
amount paid to you with respect to the securities, provided that (i) income in respect of the securities is not effectively connected
with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities.&nbsp;&nbsp;Section 871(m) generally applies to instruments that substantially replicate the economic
performance of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations.&nbsp;&nbsp;However,
the regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo;
of one.&nbsp;&nbsp;Based on the terms of the securities and representations provided by us, our counsel is of the opinion that the securities
should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any
U.S. Underlying Equity and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover, Section 871(m) is complex and its application
may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You should consult your tax adviser regarding
the potential application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If withholding tax applies to the securities, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the securities.&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Supplemental Plan of Distribution</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of up to $21.00 for each security
sold in this offering. The actual underwriting fee will be equal to the selling concession and structuring fee provided to selected dealers,
as described in this paragraph. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a variable selling
concession of up to $20.00 for each security they sell and a structuring fee of up to $1.00 for each security they sell. For the avoidance
of doubt, any fees or selling concessions described in this pricing supplement will not be rebated if the securities are automatically
redeemed prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Valuation of the Securities</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models.&nbsp;&nbsp;CGMI&rsquo;s proprietary pricing models generated
an estimated value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate
the payout on the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments
underlying the economic terms of the securities (the &ldquo;derivative component&rdquo;).&nbsp;&nbsp;CGMI calculated the estimated value
of the bond component using a discount rate based on our internal funding rate.&nbsp;&nbsp;CGMI calculated the estimated value of the
derivative component based on a proprietary derivative-pricing model, which generated a theoretical price for the instruments that constitute
the derivative component based on various inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of
the securities prior to maturity will fluctuate based on many unpredictable factors&rdquo; in this pricing supplement, but not including
our or Citigroup Inc.&rsquo;s creditworthiness.&nbsp;&nbsp;These inputs may be market-observable or may be based on assumptions made by
CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.&nbsp;&nbsp;This
temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the term
of the securities.&nbsp;&nbsp;The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period.&nbsp;&nbsp;However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See
&ldquo;Summary Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior
to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Validity of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and issued
by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings
Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc. In addition, this opinion
is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has been filed as
an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly authorized,
executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of the securities
nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup Global Markets Holdings Inc.
and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result in a violation of any provision
of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable, or any restriction
imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has
duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup Global
Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and
of the securities offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global
Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation
or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws
of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents submitted to her or such persons
as originals, the conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies
and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.
This opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Contact</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>&copy;</SUP> 2025 Citigroup Global Markets Inc. All rights reserved.
Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout
the world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp235089_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-09-29</xbrli:startDate>
          <xbrli:endDate>2025-09-29</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-09-29</xbrli:startDate>
          <xbrli:endDate>2025-09-29</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-09-29</xbrli:startDate>
          <xbrli:endDate>2025-09-29</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">7,358</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">7,358,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">1,126.51</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">7,358,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">1,126.51</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">1,126.51</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">7,358,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=A+P)A 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M<.U MP+AEIU+MZY=B!I<6,"0P)X#"PP(7G#PCVT%PFPG.)C ]J[CQY#),G"
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M&6+W/R2FY1P^ZF' @83 )?ZTT H,] !_N>4CT&0%V/U  @;8<X67^TC@W 3
M\G9A7 _0A]\![+'%P !HN879 ]T.<#0#@3'0CCW.^?M 8 $>QX &G.H3LVKH
M2JZ0KQW430&S#$QP#P#Q.'!! :^-;T&WP4T0I(040&C!R@^0*,_80Z>C ;NX
MVY3M-.,"!F"H BY0V#^.(+\)].,*%@#:$0B O7\XP#/D25\"KD !!AQ!; 7,
MC@4+0 #U=.U'1W@<>"SE/82\!@D;DU#F"**!&+Z- VKY' "V5A %+:DV"7!!
M8_\N0")Z),U7=H-0!PSXN0D@X1\ILA  =&.;JZTH0&A)#@'&I1;U6&!U!>!
M;5Q G7]0@"T8Z$ ^]F&!UK'& /$8T 7JYI^9M9 S:GF;0"90#X,,H$#VV(QF
M(@0Z@U2  ?;H(^L$H@$2)<") TB.W30 Q>%]\1_J $ ! G2[PPW@B_EP #[^
MT1X+'(!SO$F6$ >B&0 X "V@84 %XG&UZK'F 7&ZGXXJ=L>":*9WHXF  ^*A
MNI(!8###2Q!@*E ;#J@#4 8P@+F8-P '">  $U!8F*;7-P-,J@)(F(P&2K@/
M#83S0@J8DP5<T"T,(*$=1#1 !.V&A >,*P$/Z( !U)?_3,( @ ,3F$QN'-".
M#A /"71TS"<'](#S=65)-X*0U!X F@+%<I)2(PC#>DD0* ['3APP3R/MY("2
MFNLPYK-;^IJ4/^;X,R[6(4@$]!&8!^CC'X%1P 7:\0\+7L  OCL,=?+14U*^
M!0GI-, ^"%, #"RF AR0P 1":@ +3L^D_["  \HFG/3=Q@)E>TR7..6 C&9E
M2<,$S@ 8J%%F]I0W$XC:%,>6LH'PDJ-00LC0MD<1;/+5(?:XVD4L,+K6'"!.
M+U"A5A*P-7R*3  S;(P$T!)0@0Q@,[LYR$;QNA!CBH1X&\F' #J@6(<,H ,Z
M+,X$1!11L,"Q5 .Y0/T,$@]S_S6PD.Q"" LYR]N/Y%-2=04+ I P+>BT)7,&
MB$U< >!4P974 JGJK70W8B\K_)0N#*B'/H\Y6X)4X&GVU !U,% Z@N0#2>>(
MW'138D^.&*! 7E((9HKVU[&TC+6+*\OP!A"CQ RG6T"5#3X2 +/)P'%P;XGN
M>ETR-HY0X 4 \!?(&'"%S#W@!6:]"[3F9Y>\N*!); 2, >K1) 8$KATEG=8
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MER(P(A[(.$-K !TKA?4J P9@($W2+HHUUZR*_$_!P#2%Z4!1Z=SSI<:8$C8
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MP" &T(<$!#" ?#C@ ?\@0 3L^ ]"'01^7023 8QF&(?1:41CZTD$(^:.J;Q
M H"$Y!O/H8 KN  );H1(1C20@ .TIP*8)(@AW#B "6# C=>Z%@ D ,J#A"R2
M0EI@J/[D)X,A#5,$@H$5M'2[5W+Q'U>8P #N00!6.F0"5\! 03YID#1^Q0%7
M \!%H#D !_C_T0'QL(#6>JFA![C#B32)T:C^TY?#'"P !)B*!?H8GP;L<)OQ
M.6,_"$*K DQD9O,"P 58J<^O_.,":_S'!.:E&80P@ &&J.8[-30!=<0L7:/;
MCN_"@Z   "!569I MI[#/H4NQP#_.((%1)J.=3Z$ 1= 0ADO0 &#F!( ICS'
M*2N02GL4LR"N[&A^W@0X%4$Q82D*7 #\P8!XZ)(>[L2/ '/JG'-PX$T52*9$
M&" /#<3.  9P  ?:,X "W",>U!Q !+YZ.:Q2LZ1&U.92Y[.?F(DHG%0<59/P
MP<CT!1$_S5,K<@S @#,]P*_.DL@ .+"\?DQ  0DP@ (&PH R$:0=__^P&0,@
MNY _YO5#?PO>"2%&R[W@ X8OL&E2!VC9T@Q  _]PE/2D5A)\4&"+%5DB:>,#
MHJ,QB(J^\H<$Q&*!U6:(H[(ES:PT6I+A1B2$P$6. # ;I;R8Z$4Y014]&&57
M#2D5N:7I" "*:YG87E<Y]L# ('^SE&3%[)@OB,=9,]0 ]7KW+1Q@5#J*<YS*
MNA<Y""(G.%GV% S4")_VY>(!^OH P)KFN  &S=C$AY/?"#4 6#I"!<J(8"X^
MX)\74$?>#(P]"I<&G*D)WHS0YX+V=CA^$Q"I!:Y0.=/@U,2@Z>9@HC2@\DDE
M2_]M4SL:\&(QE?$>?*1O6GE<&0$HD%1%8__#XAX3F1+SR'5#9LL$4("$*3<9
M+MV%,F4F((&_:"H 48'O?&&%URQW10,7T( &>JLF(9>Y+6QMV/W\803562&C
MN;*NF[-2 (X< ";!C!2']1SE[<GXRP' @$90L&9*_7;0*#% >HY@A2-H,<B/
M?@NORLFXB?5,6I'#=$KPH8$#]$,ZR,%RJ+FB7'\\C%D<L'*;7%5/5:/D /'X
M!P(<$&N"G-%M!D@SK<]Q 9NI^2 $8)UI/^/'-M=Z)8;P)E0$I<Y[M=/9**&'
M"UPP 23P&@ 3<, SOZV/>/3, &H<R&G_$54 M",>AFWWN^N!D -?NR1LJ((X
M@B"415',WC;,%Q__OPJ1!%@  P3PB!894,T+6&7A &A 0@&@ (_P$=! -LC/
M_IV2$WAC&Q#8AAB8%8\";[R ^]! !<2XW8(4@-LV>X +7 N !UB  ]%TXSTL
M %AJ5T ##HC;E@_2@&:;?"+Y8,,?_E"%$PAA&UIP :N,7D &P*T? _"V=G_I
M+P-<(1T?_,<#,#"2"+B 0CT'=]#_:X #2( #[#U )WL==[K'G4)LKWO<)X/W
MO!>$DWDG% , _T'!YYWP@R](.PA@^)L"'K!\K_O= 2]W[4Y>\H"_?-XG4_B^
M"Q'QGF<\Z \@A@6<@"#YR  $2BZP ]1PZA Y0):N,/LC,'HA"?B'"Q(0_P\#
M/.#F0JQ R"(]X8$',[W?9O='P_B/>"  X[AO?O.O"4!WZSKZAS6B]*]/H0%H
M'P'OIM =K_G]9X;_'^./A[@)H@'K6]\J!=  KM%OE7M4X/OWCT<&SQA]\MO,
MU_P_/JU#/^<#(,D:P'_(&]$X0.[+-?2[LV@ZO^AS %"2@ BTOO]B/WWXAWGX
M@Q\1@VW F(QQM-=K" 80"R0(NWT(089( (&X *"S@ <X  O0+@.X@+/8-6@R
M@'NXE@.X.7D(/@=8MH)@  $@09#P@-2K H+P  C(@"',F#P[0I.2 !>H-&^K
M.12 % +(JK, -WS"!P<8"9<[BQ>TF0KPF- HNO\I5 A\J (( +EMR  Q^ ,(
M,+V;(3,V9(A^N*-J<1LSTC"MJ"\]7 @/^(-M^+AMB(%M6 !SN,.;D4)"# WB
MR)<'",1;64-"1+H/A$,G/($(<(Q' IH1E,2;<@$4<($.L*37 HU4*T6"$ ,(
M6( X7,*"H <.@L31>D6#P(>K2H!>9+FW<+%=;#J0@T,A\("#P( #6,&,@9M=
MS(]!)$0#>$-C7#HHA,;X^2#$^I=,G+H(J((8@( Z_ ,Q6+UL;!\#D <+\+EU
M9+$-$;0IK(+40T1/9(BKHIIFA,9ZL (DT#:@0PE6A"UO_#<VX,2/@P QT$>#
MJ #;"YBX0T<_,BA\$$C_BG Y8 * A7, "R@B'P3(CP+(A)!&H\N'$Q!'8Q2#
M1V2(L)N:2$3' ?!'%+@"AXR(.WH (#*H<YL7-*&0,P.+;'%%DS, (>C$<53)
MAL@NG(F #<!%=(P ?0@W>["TDI  )/ ("AD3Q+( 3"H K0( C&LE@@PU:DP]
MD"O'<V2(I,09E\Q&AG* <^"MDP@+>2*(?F"I N@'!:@F S"[KPPB?! ["A#+
M1SN!#$A$"! "M$1*ZA+!IGQ)>5 '%%Q(BG" #K 9=9 '@^"C K" ]@"TFT(C
M,9PZ@ZQ#.(R!*IC,M&1,@0&UB'PC2-LKP22(>MBB"HB;?Y"GD/2B>%2U>TC"
M_T[\ V0$"=F9FEESS:T0B?,;"%(BB :H  JPBHO8&(48QEKS *(T1B$X2HI8
MQJEIAXK<Q0&@D'U *I*X(YMYQHS4@"(J"--2(MY\M"JHPT14R./<IH^JFW"[
M E["C)'4,P\PA\,4 C:P3X6B&S'<F&!TBWJ#,C<,4+.L@G)("0/ Q@(M,XT;
MM'P(1V/<ABJHT)*8J:EIO0+=!PM01;.(E,&TKP+P@(.4PR"@-96@N);4171$
M ($Z,\6T# S-LI+\@WF@SP\]";6\F7-PS&Q4(\'K!P5M"__L,'PHRX^+@>U4
M"2(=&5<I4-69'C%K,?A$,+*$PVU8.AU%"2L5F3R,2/^VDT$&F# #4U'+R@=P
M-$PX7 !SC++5#)C6C,@#Z( KD(?0TI8WS:L&*$V0RP /;8MUFYH-2DU)_ =[
MH "P8+?,D3@*PP<Z1$0Q152WH)6IV:L"#:AGHC:]$52%RH<DG,5C3$8+M:\$
MJ,RH0S4OA=,&P,Z/$TY6!;!\>  *8*A+! TGS2MJ/$2SM%/+J!5/M=!C$BD4
M)57[8@.G,\8,H-),P]-[T=-LO(=@NH>KBE%X]"X#$ -Q3,1-Q0R6!)HG.\Z9
MX0";RSJTJ,Z\.H%8C-9IU;)JM1=2A,9_R)>K <_*X%&U:@!Y9<0,6%73,-,H
MK-&V?  &Z <VO30X-<E9_#C_,2#0XSA8@4%3=-32Z6E7KV#02(+2,#5*Y:"'
M21T9MH1&@X*;=F!2MM"<G*)&<75",1!2TIC143S2?/V'<ZC9R_A8+C))#A6"
MGB6-4P,:?+1/CE!%.VK3HI55&]K$0IU2 VA47.VP?" EZD$"J6.S=P+73D1$
M,2A8JQVT?T !EAP (^S27O+-6D7,9.Q6YS!:G,D'7\U&@:B53FK9JBG5UZ'&
MP[Q& (A;Y[C8/,W9790'Z>'80(,D.>50BM4I>^V6<W ]=,P',OF'!H"U;@2D
M9^50:<V0PK47K$U8:&0H#J@ RV1<+I)/D:79A9)<;KG6;&P'+V''@$03(@2@
M3RT(_]X5R;X%FI+$SD-$QL&]#T4]U])]1=' B G-O>:EIET# #"2, !PU;A,
MB)_EFWRX5#@L37J]#]&]U\.5Q(S8R,Y$B=/R$H_XKP=P(WT8B([ JFSYU^P!
MTS"%7!XIV>*L7&ADSJ^D2Y,XAROHF0@P@,&*&P68%WOH&:^<+(0@N@("5X24
MPUH4$FX,WKV=N@>(!T/  -0EL"$] H\H(PVX.3L"@*HR@ YH#W,UH@D03. -
M&'PKS6TP!W'08+)ULWZ0'D>9'IJ4B EP 5'\-HYX)" $ /3]3(+ !PG8U4I]
M'=_, (E]6QW60WQL6I*HN@.X *W!%DC]RH'@HP/.%LG*GO\($%B0"X*JS1 _
MFYKWL.*2<#<+ #K1B(>HF@ $F+>,W,C5!%:<*4QCK-.Q91,7AL3^C6,#TH"X
M83ND8CN#2(  #HVG%9GN#=/ I13QG5SE3>2*,-Z0D.%8B5EKK (R'1)-YA9\
M[>2WT-YNN5];!=\P065IP=)5QHR7!1J#/,R08^,A,>0K161;7M!0;I.2!-N0
M\X!/3I12HE%AOHR@M)<(:("RE,4_2.9NF>5HP3IGMHP_UI6O3<2E(U!EII1>
MS$=N]E=B%I)Y7("/JU-31N=X+HGZE18/J,:/.U2BE>=]_HAWU15I_H-VMM6*
MS9CN!)H$*$]^[@IO;A,#N,X:1L;_7IZ<V/TT\E7HE(!F2BF >QY',9B:;-:5
M6K[HKFCE(0EDA!Q0J@%I/+/HD38)7(85? -;3/YHBHX60PAFET:)DNZ049Y/
M<J4:Y,490R%GG2:)C!82%DUCT)6<E8X5E#7J]U%GZ'C#=@:Y^MP<9@8:B(SJ
MK$#JGD[">@S.:_9;?7;EKLX*GJ8/?,!.[XUEM(;KB/CJ_ !3^LSAN,9K@V!H
M^@C:[+3@]L$ 21Z9[\SKDU!KYR!-8SQ-L]Z:7Q89RBULDZ!G_'#H#)B'["1D
M]W'J,<OIR(:(PSZ.MA796^V@S:X4J/;LA]AKY?C;2Q:#HG8>TZ84RH7MU*9.
M2EZ.L(Y6_X*V(=E.E VR[8\ ;= P2',@9<9V'J'&PPV0Z."^*2B6C]:M1^V,
M)*AJ22!V[NR=ZK:X3I$EV%[:P>P6F+MN)=P.KA,@QZN&9_%6:!/&IPJ@32&J
MAPGXH0=$B-6^##:@9@@P![)F;[@&"S3:AP&0@ NPM <8@-R]HRZ^;>@ 5VK^
M W%8;Q$R-J#1,;A&PWU@N[/KI($C"(#\AW887'\VC2IX4%MM[@ZZ69R!;+0V
M@+N!0HRX!PVXW4AKX2 B& /  /-^"]_$5#B45N3N;9L.:4Y6: 9  @Y(P!NY
M!Q_BRS*BA]4"B\K<[@G]P%1%9LOR;41A2KQ.VY$8M8.H@-R\S?^S(G'+*,8P
M+5[2VG)9,_)]-JVJ6F0'L >!8#L,P"<)\+EFFVS*.(%U$%ES^&O+4@"3%9G9
M=6DA[ID'<  !0,!^>+<"ZV*-.G.W\&DQS5_@H@?V9/$WY^?:=@C\U@K]_MS,
M)JT*QYD&V+'_?HBY[@HZY- J* !09_5:#_4JGX@TMU7_MO5>!XGA!@FD:VL;
M-O7KVE9?;Y\^UPH#Z#CO+4?>!C -X$^!475DITY<9PCN7>I!1S !X'1(;.E:
M%_6/2&Q#!>H.:_,PR0=TM7:#@&FM8%'CSDYH-[%T#Q.!:'=ZP_:#Z%ZQ/H$4
MERU[!Q-$1W97KXB2G&(Z%5L]$_@A0>W_7A_WA_CSF5Y"6O<NQ\X8=L_WK^#Q
MA\@':A19FM8S!)\:!DCH?(]XA:#& !U6TM[XEY?LJ6Z)6$3(I0-XF,=Y>NOX
MA:AJ^GSKG =ZAJATAW!H(3C$7?^W"S!TKNE8YU;VAF#KHOR#GW<SC!<8G,[B
M=A_N>73="7>SPCW6C#P+WD5:-E'E:$+=C-Q*#>-"2*$ H*N +5GW?G7F<0]8
M[^9V>XMRA6B'& 2 ^M,'QMHU'J3[ZE+>65FX+[HCXS KK%4 MDNC?> KG39X
M -#VHQ_'H27!PI6'(M*,JTHC&6SZ^=@ [%Y8:GE ;IN "! -'_D'6,M=EVYE
M YAF*D9&(1^T_\(%HHR4AY&8@*_" ,'C<HM.@*L\O_; /5.RB@GA)#,)*/)F
MU7=7"#0&W+PWNE\F)8]PXH*0 .- \'\(?#=GP45. -O4@,S,!_J^28*0A_9@
M *P[+<&6YY_E^D34?#TTZ)M:V&_K&4Z2@'H"B $'!DR8<   PH0*%S)LZ/ A
MQ(@2 21(\/#>/Q<.!EKXQT #@P,6)ABHX&    ,7"AAP,"'?Q)@R9]*L:?,F
MSIPZ:1Y $)%-E3\0MD&(427"SJ1*ES)MZA0A/I<&'L1#.15AA0I/MRHUP
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MZ_91/1QH7D\%\1#@4#]!XF2 Y#<)L-9-!T@8.NLT1="[30SHCA/R-57 9?+
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M>GJSRTM=>A<<-74@R*E D"0P2@=<($@,"*H#'("/!^#C .G3"0.NX *OM D
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MI>'/N4C0CBQO*2:9@'XK<#3?W"-^T9SET[VGWGB<0YL\O=!*)NR 5BOE "Y
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M6G!BPJ $/K";+&HB: 2B/<SB'FY>*H5& 1R!5FC "X &DJ@':\7+A?0BDG2
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MX5G ;S5QN-95- +Q>%7KF8EEAND9=LXP6R:$/I#79ID$ - #5TI.JFI(:F'
M=NZF>&E,CP%(0O C-,GG1NX8/BBF>@DG0T+I$ 4)K5I 9;W7#(N=1L19W*PD
MDS45K>X<_[K& $6A:$3AM*+40NP9 M2DF2D$3!QA1!0 HBE$*Z=%3)A/<+PR
M0N2#6,C@_*@'+5?.%4P ?2H$_2P$)A7 :@2SO3!M$Q)PVZ5$1)0%+C,S3=R#
M*C_$---3<.!R H'&:@0''S[S)E.(2B ?0S  L(6G_46:"SJ%T.WRXT$<X3>_
;,SS'LSS/,SW7LSW?,S[GLS[O,S_W<X@$!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MUY[[[;KWSGN3>!X)F[8\HKU GU^ZO?OROC/_N_/0-R_]\]-'3_WUUF=?/=W
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MVF/1L\<E 8BOJ2EM%>=+Q?I>T;[TO:]^\SO#TR31$%J\[D?AD0<3;):\%:A
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M]C$' H/__C%G 34&:V>!>,8!X( >(96'4D@!H -22.D X%)..\74QTI#U10
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MCF_AWA*;A:SEM3:_-;/D0.^1>*!PEB?&"W<HI)3Y-3"!"K@"T_L9 ;R"*+B
M29#M_GYP4C'YN#8TBW/PEY/2_A'W'P%/%K<[%/<HE%P:-5D@L8@O*%A%2'/S
MA8)P;RLK:4Q$_R8W/5.&]K))+QT&]XGARA[!@O&2^87W=$M<^%F9!"G'<!O.
MQ#P,ME&TE7(.RX9R446*YT4F,']FRMF6PXT[=C</N5;Q.\,G#!S*$KI1G#N:
M./I .J9;( 6 $;\_O2&3Q71?)37 APN(SWX#"#H ! (H>,4! 0=0"I*35W#?
ME2M1#A2D", BQHH:+V[,V/$CQY 4/9+\:)&@FG$7^RD@X#)A-0!YUE40)\ZE
M@RAY"HY3XW @R(PE11:D,PY>'C5Y#KQTV8]BSZ)2@VXD-Y5H2(%J!FI)N*:@
MFA)=FSHP84AF"80X'TA5>2'A@Y-@ ?1427 HP;Q%5:IYEQ(H8+F K?\"(/QW
M*U^[5?=F#3QU*.3'8%5:[?EN<D%V  )P[NSY,^C0HD=_-D!OW51\+0F(<Z#V
MI8,KAL89,H%P-0&"X_1N%+A;H^#(6(43IWI@1,LH;>]N! SO04L'U<[R#&#;
M-92=A:ER+QYR>$'PXBGZU2@/GFV<+[_!*UC-P0B7XM;DB;H](_/OXYN7N/(@
MRGNPQ03 5N7]MA]6 CE$F$5^J7094PF50!T _;PDS@AE[61(6DT1$,45=P!P
MWD$*R":/8N4!)@]B^65TH%Q\%20/8<P=R!R-(Z;$XE0XUMB69(YAA6!&/ (5
ME9'WP$,:DTTZZ9D!"QQ)('0N:5%-"0_<Y)+_ M5 48U_'A) D8N \681D=VI
MF69A#G'8D@(.7'#63R>I-!!?^*S1%%M+T4''%<@E)%M#XK')ID>(,O87.9<!
M ,\DU<#T )<#UJ96ALKQU%=X:);DG44/.! G;C#1M5U//Y69(&,,,K2=0UO1
M$9\#)>1AU0%:DK7&67G8-L*6"<G)TWL*F$ @G@0J5I>0'N57Z%:<NMI82- F
MAJQXTW(*E%%FJ@0J2-UN59BC/C$+@&9/!B"3NNUR%N6Z#AU0C0+U/K"5(>_%
M1X "E(XJ9FY3Y4A7?ODI^AVX;%IUT$M17(#FB#\6- E+K\5V1PD$C-"/Q;+1
MM=7 (]%!4<AK"G>P_[-3M6<(/J+R6\$%M^'3'@"3$#!6;%/AJI%B! .WIB%K
MO"8?=CKJ['.S/)\I\':5T8&3K17M>Z$)><"C6GQ7C)50=FI4J0!]=_+&&X\P
M]K;8M009N#2LX_JV:DGVZ76CR=R]_:K<!=VSF9,1[)#" A"X^^0!"]Q:4!1J
MY4/?B+H"[.%-GL(J9+<)2X[RV<DBJU(>5Y3J&@'57'"JD P#7"_ <1V)6'@5
M6*CIE C7?7"WG8+E*!TE1"&'Z0ZL,8EK;"7[IP&4]C-)YF.;:7N"=P*0)5E8
M7O'[J2DGBU>XWVZW_4"T0L'/G91JG$U"9@6-4%S XC2=S2_9*FNX'_<\5/^A
MD\?XUZKBVC6_W3UWJSSFJ$60Y:4J,WQCT@)VD(4LL(,/\@#- 3L3'KY%,((!
M0, "UJ62]/!K$O#8X., -@*!0,PJTPH.TBS'/!4"144'L!# 7%,-.M",=./8
MEP."%4*<7$ [>KE E6)C"*M-<(6S&TI(Q%:4 QQ@7*0[P$%< \.6,#$B):BA
M$P/DP67=+8E3(DC)OA,%]<"F KV2$:N2)L >V0X_4)L+PZHAAWI5P 10J("]
M % EU@@OB%L,DF# V"*06"5'XQ(,_N*W/#5:CV2#9.014X@T@A!F;TY:@07^
MD04 [. ?G\'' B1P0 !$8 $+0$  U&'*<00 E*?_[$SA\B"0/%P 3@[ 1WAF
MI<,=9J11R')4+C-W,A:>3'\5"5 .=QFZA1P >36[ EQ*4 'QQ7 24;RB1:RR
ME(1H+"<7@$()*#*).Y; B &L72Y5(@]#R($ _UD#+K?2H5TYTQ#4(=.=#!'%
MT0$0/U+IU@D+D@<Y=$69TB'=FO*GO>M)!4VUDX?WX($B )@@3B:(4(;^Y0"V
M0$$M_5()=+I$)H:RBEGYV99O6">80N4O>0O%7K+<%LDTBJM.;&R3 9VD#C[L
M@*=9,(1GQE&."PJ.,PS81V<,(+AZE , @GL'/3J#@*@2B$-J>< =:#:).''S
M0O'!$&M&:#M&%:0$)KB _Q+I%L#+)6R %YD$=$9P!4GM4H:4@D*^;B,\ +P'
MK#H$%'P\N!$UF,XEM!K6>Q""5D#.="!0>, #/$:0*";$1./(PQW@<Z%J7)8N
M/_&?01#BS#5^9X \&I@7.=84F\CG <PA9I ,1K+-/4U"VJ%HG!;BLJD]H(<=
MW=<#K%8EB"W2>H+TF4G_*<GM%4>MWDDI8\_YL;,=J)(6' T"4K"""  5- :8
MP $Z X$)+  ? 6  *O,@ 02H@S-2XDSAXG$G/':IB'>H!IA*H#Z- 8P^Z S/
MU>+D #F,:(*Z*2*"D7@Y!#.8=&X%X@/Z82'AT<$$K/'0J#9Z 9:82B:1 M9&
M'_^@O@MXKE84HDMAAS:F>:FE+/><J4=*!!]/>:@E!L'P@.:BE0(#X!WZK)<'
M<<>3YO3R58PI"@=?(CKZ#FB !^[QC(;<X/ X#\J+J1\=M*000^ K+2*@3S5T
M>%"K-@4*%G8)17:FQMJ-JRX_"29@HDRZ<0&SB'=ZLYSO7,3/[KD@CKI3E:?,
MX$ SCS<^"4^ZFG21 _3D .L #0(8P !8/G ?"+@'*N$! 004U7#K6D $(KT/
M",1' 5'8AZ0EO8]]X(,#&?.0%G*(DPJ@.M62=@=^!46 >]BZU[[^-;"#+>Q4
MX\/7^ZC OQ)2 4DC (,5""$UEZUJ5B_ !%& 0#;J59;_*+3D =6& #[VD;'5
M1.'9P1HC;C9J @@<E=6U'C:P1\VOET"@'JAV&9\8@&SY !?>JD:V B#P;F+[
MV]?%EK2NY;-K!-!+ ;0&]L$++O%>U[H<KLD)/@X.@2@$[MB:;6VXSPR;VTA;
MXA$G]L#]?7)AK]S@PVXYQ"<N<V%#X-%-2@$/^$ "G8>W,ZCAS 3>P1F^M6/3
MJ 2 .@XPZ0!(0*I2*@B^*]>F<1#F"CHTT06 E8]J7(:$,K%-J40TCI%P1" C
M6S3:R?XICN#S3[LQBMOIT"@UD$,-:;Y,%*@)DV\)?1+*C-ZI&J7-R\*#'-!\
MP"28TI+6]-8 KT[().2!X1@2_\  :ZA %""$TT)Q?D&>?Y[>?4<7H1'-L..
M0KVT(+Z<D=V7:>;(.!H^">T9Q>[W*;L26T^@D:S6L$9!M@-FK_G6TUT-M2<3
MW)._FY'TQ?B-9OOPR'.!"Y3  .02Z$[>$:"7U'<<[W <?P=%&);N;_.[Q[W=
MZ>Z7-,L+3[8OOE%:/Y*&U+WNM3]^88J?YOOWQ/YI_O]%^ 3\C00!IET!_LE
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M.L2#N[3##O2<!+%;!C8;4?4<!=;#T+$;E$A S,!&)RI72%A3L-1*'N0+&3C
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M64P(P=#!),!5#@E1EGT<&$(%DMK( )'>H 0 Q0 ,\I!9:Q7$$,'_ UKJR+6
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M'> >>9% 'O(B#Q4LJ%=-=.(3_7.!.S O/_MYHB&N<+S\'""+X&L>SG*FH#N
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M:1'S*N-15*GT0B9U43F4V:C1:.S1/2OW&'=G'?L':7:.;?TO"*>5,%/GT"!
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M]?+KVX=._[[^_?SS3\^?1SF]Z49@ .O_R$,@ "E$P X# ;Q##@(0J -!;Q!
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MWG[JO3<_?OZSAW_[^%E/>P.$'P&E5\#_W0]\]4,  _NGMP7Z[WO_>Z $OV9
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M?VLJ6 %WAHRU,&H?V^&5IE:\:66M.;6FS;'_GFZ:J:LN.\>IQKI^&,DJ%BK
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M$ 84RD.5'5Q&' !M5.$3/H2-="![V0AT( ^A183_&$($&3Y$UJE(BKP$1 "
M*_%+&;J22\!A1I!#1,3).$3$7^0AF-1&?. A1*C$&@(B'81%1 R%&M1&60CB
M$:[( :"A';*7C$1B +RABBPB1+S#'^[A;5PB(]Z&(71B0X#B)(:&)]K&.T@
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M5MU#[,.&1D"A0@0[[,#2,H0ZS&-M,$ /5.A#0, .5.S,64!J_D9#_,,]DNE
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@.(-3.(>3.(O3.(\3.9-3.9>3.9O3.9\3.J/S(0," #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MZJNKO0+[ZZS!$CNLK<4B>ZRNPC9KK+/*0LOLL]1&.VND &#+AFE%RE1 DN6
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M2UX:\Y?"["4Q WE,7SISF8-$9C&EB2T $.( !W# !S12@ ;D12 ^\28!//,
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MEP#9!1.$VJB56(BRP4M7J)0*NXB >"H']:&/$HW5:HG0>;2NDK0;FJBIV+0
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M3_.Q*S\W'\DIC_&@Q_,N7X)-CWU/+W.6*_5%O_+8)^R64NI*BGYRTZ'%:>L
MHA^$0+,7=0)2@._8! YD=%$>T&9+"/?X:)$WZL/]V!'$Q]AJE*B0N*CZ&;:,
M9X'R^#F8&NL;_'3E4NXF&93X,>X,][,5_'>0J)^X^+4?;XP+[(/8N8.Q_O4B
MZ[JYGC[R6+603Y&7?_J9WT:;_S&=#YX/BJDMZ?K9"H2E7\6:_^RS-.V.*OE,
M^_I:O^S5%_RF=_MYFZW3B9"(FIYI0K174ZPIC"6G2PB*_TQFS/SAA\MGFJB/
M B(.ADMFS]MRL>>KGYA&I($E0](UXFGX:)JOHBHN&,]"W>BC&LOU=+KS  $
M' ""; "4,UAN8#EY"04>-/@0(L&!#<L)5$C00$1P#!,.!$" H,B,#Q&.+ A
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MFW[HV3'W > $*%V $(AT !PH;X"[II,[_(LV>SR F+7A1P/4[(X -,!<#P@
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MJ%A]2>I3IO#.OG40J[TY5P>HV\]C'H4I?8=;/YK@[_Z:*>J+.[?L']TCO[>
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M)Q&"(ZG=!>AUJV='-GC)N1OZY9QY,+O&X9.'-_^]_@*SH2PZ*[&'=X@ 0NC
MN\?[O-?[O>?[OO?[OP?\P!?\P2?\PC?\PT?\Q%?\Q6?\QG?\QX?\R,_[<\A=
MU.B6#A2Y-3B!<Y!\OV<'2"6#.3A\0G VYE0 -A@^U"< :]MYWQL^*^F'!T"S
MSJ?]VK?]V\?]_]S7_=WG_=[W_0)@ASC0AUC" 78 ?@Z 4>/O_2>)@@+@?,,O
M_9F7MK@GRC!K $)8?:6<@[+I+VW/MBX!^_ 7__$G__(W__-'__17?[ OGN$M
M+VCI &J1 B5)_T08$BGXC*,7!W6HO70!@ 8 " 4/" 0@P,[> X$! B2$D"C
M/0D*""XTIR"1/#8  &@$ &YCN8\ 0H(426"C2)(;.ZYCZ;+DQI,;9X[<**_F
M39HSRX'L.5/DQXXB.V9$:72D2(Y(5QX%RK2HQYA'95)E&E4IUHY83<Z4>?6J
MRJ]>#6PD:Q9 50!0@S:U^K'HVI]2KPJ=NK$ESIDY-9:#&E:F2IDB<_\"=GK5
M,%2\?3L*;IMU+M?#1Z&"3:J5#<^B/),./=H79,[/(W/.C.;@P($%'CJ(Z\I!
MR)S6 ,ANM7OT:ERP.]7J9(N8[U< "0 L+&[\./+D]A86*+"0>''HS_L9/Z=
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MD*1JT=MH(BA)8FQ)ZT(F(HG^(-@?TD4Y689YL;STY>/F1"<A"G#.,1M '0)
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MK*0J3'H!W<7I!^4A2J:%JQ59A)D(V_"=J8?):DG5%5[@!59UW&<A:F#QU.7
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MS:<DS8#1M$6GV639ADKH&[_HP 04@ [(PPT0 M:J#Q]1EHFXJU3I",/T-8<
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M@$,'=  '&')N4I(:R?^$$." ,*(&LNB2I @N?0L7VMA:XVSUPTK&NLU;1R1
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MPPX&'9P (,7! 2%W/:(NO-HM8M275=:\">!$\8/HA(@KEXB#]8,'''#XZ9"
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ML-:&#Q>;L_=L*T]9L:L$M37[I"(*-2)/*]TDXK ,RYG$SC-"HE"SL005=;-
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MKSF6W0:?O4:>V9F0!7J;Q;E9\&%;H<>:CN(<M, >= !&T@<IH!8I5N2;FH8
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MVIJQ-KKRV%4BUMIIUBH4NVGSUD PW%(N&R,D/^,J J:G>LS!\BFZ+ ""C0$
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M4/]^TD=]/N9^C3%^%"$P6I%^Y9=]]#=\%+%]!H!^ %  <1 %*+(=YS!XB$8
M]>,A![ &<K0. @,.Q2>!ZU .< 6"'( \:T-W'A(%9- !ZB%\R@>!VF=\^L=\
M"(B#2#%^U]=_(PA\OP>!S#<5Y3=]SI=[Y1>$W$=^S,> -DB$.?A_\O" .3A\
MOG>$3BA^!?%^WP=_!?%]' & [T=^9^B$#OA]0\A[;:A]P;<=4[A_S">!]N>#
M_#=\5HA\%'$44ZA]T\<1 ;A_V!=_A!A],/1YSZ$ =9 .$* #-\!"0D< YO
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MIDT3O&)"$SG%94V?5[PY4-5 @O,]-3&G[*-&],0V$3?='WC'0B %SGC(AA$
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M)(_<T9QSV&&G VT((:2#.>8X8*"GHL"! W;F(. <<_RQD4DGP6R2 '8($+.
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M'/W2\,ZK-/ZK%ZEWX>%M=:<;'H7T=KK:U0U\@[M)2A)'-P@J!6X-U![@:O(
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MF ,R,R_ULIE1O)*"B((:%"ZD6#6G@T.VBT"(VPLNO#S\N\6).S'A_V*U)51
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M$I#.#D:3AV@.28C*W)$@=C&_2<@S,?/_"G]V@Q"?7>LI=&,,\_AC)2MM:W=
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MHKH-$N!PD:;TG02V4=CP(1S*X&JL8'.4#DI4!@Q.2UTH3J>4R21YXYD48F+
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M)JEZ;?_C3)%VAD87IF[X.27 C V4P(KBK"B]RJZXL@C<2,WF[BN8TB5ZZMW
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M]K:M3>UJ4YL=YR  MMG!;6UOFQ#E/K>XS>UM;KO[V]E6=[79 >]JBQO;^"8
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M#M]")"#8)>0!J7/2>@C'(,6PPVY(2L@Z[%: =+$0+YEZDWWFTZ\@!H ?Z8H
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MY&8&6"UJ=Q "N!( 4("] G"=<0^>9QQ<L77_:R=W?%,3DP,@=[,5$$=U8/,
M<Z!#'>AP'U@3%7@3!W$P$>0Z#]--+Z(15E03!3@?UF04 :!.ZS!MGK$ZLL1U
MGL,W.TAI "<2)T%#GY$5.M0R;X)P&@@ \J  YZ!OG=$R?C894!@34C@.RB>!
M-8$/YT"%4V$3U=*%0J%# ! ]$M2")@,K]P,9U3('?&<<;<@W!Y%$G@&"!1 5
M-*@:Z^" ?,,I;A@1?C@:-5&#8ZA_ZT(;!<%7:>,X2_$0V'$>UL$V=? !/^45
M,2$XZ&%O0V$33:,2AH$51<)%W#$.9A&*8U00M4<=!) 2T*$ (,$78F$4$5 '
M 00!6I!!1!46#P&+_[]TBRN46KLX$KTX5=EC1;1Q*2U$'#8A&3N"%IF89 /C
MBS_E+G&F Y<R>L1Q2P"@?#RR%Q$0*C W$@I !P&$#]ZH$@H CK0ACO.V%1X6
M':@Q7CTV2>]P R7Q-]HWCY>20;P1 /:0CP: &H@!6!,!D+_(?0DA#[%8$- 1
M)^O0#J=8'B"Q$*TF$>J@!0&9/=!!D<2XC"+B2Q2$&CGRD5(CDA%Y/B9 C&GA
M&3I@ "$"'?XAB_01=Y#H.O.G$NS0$@Y1>RY$*@^0<7-5  (1' L6$S"D=D19
M$#?Q .9BE3%A1T@13'&&9T2%'06!AF^"E.I@CG-Q3E1'8L]G GI!-C&!E/]6
MN3=# A'!H92Y$93R&!:&(8Q6"41V>5)TV0"_EC($XBOIL)=JUY?,XAD.!E T
MA)<203[HZ'A3,0Y Q&<(<6C=%AP UU5[QI!Y\DX/, [F\G Y<DXZ] !,E4-3
MB9()$5% - [Y& #G$"H I4,\%1/MT!JT@9N6:970X0_GP4\F-1&\%P#BT!KH
M471.0II I'@_>1/@F "D0G4-\ [+IA+^$ \)X"]A1 !:ADUON2SFXF<-, [9
M:1RT% _>Y89:=C)@2)YV!DR8&4/=Z5UL)H+P811=!$3FN4@WD0#3A)\Q45+Q
MHD,S*:"2%!/K0)U+N)XM<1,J)8)<\@$*2G5<,0[_ '<.-D4^[2>8"?)U 3 <
M5XFA[C .(AH=\1 /[I 3,>%(@4.96F(""IIV%C9'Y!<=#)4 +MI(93(D,>$/
M_7FB 7(/XS!Z?]<K#8 /-S"8H.)?:G<#^&"9[L!O331V#> .\7!&-%0F\@ W
M[P1<0+1T,,A*$MJ=V1-NT5D@]_ .-G53IT$F=",@5<4E15$.T0< $B51+20/
MF#(7>(833HH3,(<E,8%!$?4.HW<< 92.OJ= 1$4TAYBE[N09B&$>8BD1$V ?
MD":I2Q$/;MH Y.<?"N*2-[$.PV>HUV%O!9!20I%T.E%!?VF3?*-CYW$W"7!1
M\0"K"5!!@RH;03FGVE< _Z!J4VPV![%*B=(9$^EG9&@X.6^:08RJFA) ?:\5
M(6BC!<4Y.=U9J0FS5<<Y/%9T?\!#>0:5I2D%9XEPF.\2 9D**O"WI@$2)V'A
M>@&6+C-3-P5!HP6ZJ7!4>[K!EA%*05$D5ZP&$A^@;]01''$49VQY%Q)Q8U=C
M*P?7EOEJ;1& %!7$9HF #R;@%6&$,12;5Y<"'>+@&,%A D)H56&A!3:J T'B
M%,"D%ZJGJ28Q%"W$(_7:0G)5I]=$LUZ$&)RBK-$Q'%XACM:UD&#8*+Z5F<31
M '?$/L-A%AE$L1IRB0Z!*7?S ?Z$B[.I0</Q 6.(,'320A9;G % "%PK0W#6
M#__OP)8S>9$6$I72(XO>=XU=^P%YF#DF$+:S&:D?)H]Z<23RJBXL06  8 +V
MH6WN !1U8';& 5!S-'9#4I\(D0X'A$T?8Q3E!A1H]&LC9:;( T1(JEK!$92$
MT+D2 &T-%QQSU  *URL4&F +$0_W "+:60?XP!30IA@%P \IE:X!(KODQQ(?
M,2$RFAXG<P,F8(@P14LK2TQ_DZ/9(A86FGI:4 #WP+Q2N!7\%%%LUROX$'4I
M(QP58V_IP0\%L!W."U I-79R,9_E)QR 86^+$S)U<4$@$QPIA:1;@2YNY@Y!
MT6(&.Q6^R+N+N2\@-4<&QQ5((:&_!P$D 1W@(%ZO4F[_0FA.U^D.>6@<O>IF
M')( ?:$%10< %OP NJL8:W>>G%FXZM(.5'(@=E,.AWD>9SD2$L 7Z; 0]M$/
MYJ$ .4HF1V1D';3#JJ5W[Q)<T&$/XX 8^)"CZ!([$KD2Z9!::I4N7;$01OQU
M!)##Z0!+5:DJ'5+ 6T$?KH7%YY'#Z847B$&W"!'#Z#.SP>47#Z-:0JMV9NQG
M5!(!A3A\5Y$C.9(.?K$.XS5>&;0Z0ONU).)8!. I=Y-:'ND7\E#(FCBS$H /
M8:>WV.:SF0G)5?$L\S%>"R%X4I-:UBDJL7&WKF;%UPJUYV'$22<!.VR=;!(;
MRJH;K!Q%:S''EDQLS=,AMCQZ_V8\5<%GG I@Q%KDP@6R%@TPDV='"'X7'6V%
M*1'4*BUT'+228#!(RC=!B:E&:6NG T^9,-F<-X%*B7-@ G-0#@: 'C=!5W,P
MBH\X$N=L':UR#P:P.A]J$A] N $R.39*&//7*K!#%1>+$/? SR80T(67GK3J
M3=EB $-RT %@1T-AKWTW=T:F717!!A4BH\M3-?W,=I.CT:A7$.RP=C5K;57#
M%A(PSU :>T'$%@0 0BM]'6L1%H1' -S,K$U+'_X@#VKK10KP#KNQTSVM$A#0
MM,I,& 3@T2#'9J6D:G)V$^0SSD[B-A2)%VP @!V8F%1]=A8Q:E)38%.V(]5,
M $A* /]-#%QG9P /H14?$$V?A1<11 #KX&:*9#BF:JFN.;*.E3J3(0\%$-5\
MJ!TZ *<!PJ/V =C7>DD&4  & +F>P0Z(74O#^P%:=B>#*6#&01D0IWF$8=F1
M-KO$!'YD.U>X^]DFLW9L)@X/4]I=-Q2AB1#^0$8%_-2N[6;)(UZ$ -.%\4$[
MLKG \QMIO=84(1YL-QNFNM4I8R7/M';P=!/PE#XAH7"Z =A-/3:-@1CEM14Z
MH+C442!X34'[=;4T Q(/$7(3DBVI_<\.S5.)^ZUM&6W8<BSM)QL.O=J!NQ)M
M61^$,0$^!;@"T@_[W5VI,Q1M6=4-H 438!$:7=XJX<\*X5O_21(85;V^;^'&
M.T*^!I8@@T9@"VXE&M[%FQT@,ZAA$ZY\']&6NA8 [& 7[ !A!+(S2T%&>@LF
MAR$!50HFW+$J!/(3<&8.9&0"F)6*>B&;/KY6D.F#I[$?Y(N+>B$0^2@!)6$
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$# @ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Sep. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Sep. 29, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">7,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 7,358,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 1,126.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Sep. 29, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 7,358,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">1,126.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">1,126.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 7,358,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp235089_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp235089_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp235089_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp235089_exfilingfees.htm">dp235089_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp235089_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp235089_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 1,
    "http://xbrl.sec.gov/ffd/2024": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235089_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235089_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235089_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235089_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235089_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235089_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950103-25-012450-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-012450-xbrl.zip
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MTIP8<XC@.M-SAQOQG*1S6HCGA<;G)97+'<PC-9ID08<A35C(R@@0 G:[YG)
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M]!Z6P<0<-1TCLRU+"=QK6[W.JF:H8RF7C9J0??9F+9?C4H(TB_K.I!#FZ&J
M)4J7+<K:<1ELLT#6*X8G* ?-D.D..A:9%U&3(GK8E&H+P(N)A8XTN%*E>0_2
M4!L#5:159!MF35"@"2AZ380=$]4Q8Q,Y$AIA9D)?9@P8R!WM4.$_;!#+FC)Y
MKJB*?\T];(37L<8O%,QG9ZH&P[4L['&X'?XZ12-JBKZ$4_\ENU3!EB#Q[3\D
M3% #6Z$Z MD2^X7?^9HA\I"J#D3__4^MJ)Y"$VPN!U(SA0106A*@@Z,J)H)*
MANMD9YC*NU-5 I@=&N:@LAV6[P7KPC]LU78\V?EVG,:',%Q=6-AX1A 2$7<M
M"M#7T&Z@IB VDF.H)4*$D3/*(3+@K11Y$[EI])L<F%K=PIRCMIS%[9UHRQ7^
MX&^_5.38OXXM8V#Y(]&S#LM6T>W@ /+5;'?@B%B2B^%8@A7R$>0QZ'YU)2F%
M3\SU7 [9\R,>4WM@H[!I#J3\!-4!09^@E;N'>GSGU$.BM5Z/D9Y\+122#R@?
MQ+2W0'?GDDTMYW916*M)UY'=PL; M+1.@*)H/BI9I"N4E2S_?>?P=U[8="L;
MQIQLYF5SI72LH9"K%40%X#&6)ZO%;:++;?*B9(X7R-\O09B*^U20M"RHB7SY
M,6+86],H?F)DR*W))[-A]18;F=A0&@5OI&1#(RH=U[4(=KK8DJ^9HC:GH/H;
MF@.;J -1"U/S96.Y;I^_2H P8MT98O*RXXV+,&-44ZJ7I".VXBXA!Y!WD_&@
M)^U\T4=BTH&=;A-F@\<XU&7(3[S!BR_Y1NQ5:G[IMDKU6'O[ZF=7O_6!5)TO
ME-CV'B;88,[!<DH5$!VSM]\ML#]:BGAN,&SX^6'&=,T68$_0+FQ74T%R'.;S
M/!VR(9,8U(8-X'>L<=:=@6VZ8KJ<S!7R2K64RA5.0JE"=C8XY&_?*R.D_]!W
M9;J',D.Z<$Q8.1N-2=IL-;Y;UH)2U5*JJOX 6:'*$7%Y]RMH<6K4[85-L,F6
M" B15U92,:'\H?..I2HI534#$FF%G'9H$X*$L"OW:[43Z9Z:7LP45HCWT^9H
M/5F.+O_$.5J/,5J$8N)&] D[=)*>8T);&-QFPB$M]"W06QPR,^M[R,S2$T#)
M3&;H[7UK(3L7]==8[&=,SG,N( ^\_**)>4[.?!#9?\6\/"=GX35R_F0I>4Z@
MXJ^7DN?D*ZTSV+I!3G[K0<[BQ#O)R#L1S*[FZSM#M*>!_P_'<Q#9UP\?9V\C
M=X!C5WKY/Y9Y5W,]+:^LB7%M5V!K-OX.YL>\LN?XV196=$I.QM'E!PF2Q]/Y
M.#R+H2>O;D8WW=F5&L),LB\-E/?<V&WE9GX')KLZZ@Z@L?/;L VN=L [KS5A
MU*;NTY E=:MR8+]&E/&"DXUA8N^6VO0V[-41^17!#/2Q5_MK/][^+2)\ZU\.
MR$]I^=GQ,&5I;-[PT)9F!VWL.7B7](3!.^L?,)L[.Q=\/B2/B\@3)ZC&*+92
MZ#VQAD0Z1@K=88>G_2^(3J7]708B]SK'!36EJ5I*+Q3>;CX9I\9?@GLOZ*\Y
M9U=<?B)4J7Y-_,<_*7 452YR '7,W^[DQ%VBLZLKS]YMW'M_#;B@W<FJ[JNP
M]#SP["75DBH7-)==D\4B@AO'A%*+"B+<P/)C'RW1\+B4@]30)Z@;G$SN0H3P
M(+&#@D0?B3[EX8HW8'R '2&'L'+TAH*76N#^L"T!DL1>#*.:X1]CT,JYG']*
M%%@%,!,=2SAE'E!YFT(C@'%!4]3!%I06IOPD2;YKI@["A@$[7WYC&? TI5T\
M[L1H'\VCS"R=Y@7[#?0\VW&_I*?I/X^GQ6<BI;P\>X4X\3"3IW;@$4[!?L$A
MEQ&U+#G<9\0@= BFAXCK>U4OG%VG_,.Z2]W06>V&*>3$:++XN1KIZ^#?'IY(
M+TCL,\E..._W0',+,RG$$-(YY8;E<O\SC-6'S5=&[".Y]^WIB2H<G:@*#8@\
M_RP7;&6I63[3+&A_U*=&W[_O,9=[Q! ##@J6G])SJ=??UF1?QL1PZ1#UM6EW
MPV'V4F%=+YE9\WVK QT"]PS!E[QJ",EL?LU0*OI1]BBF*= 0AM@* 2^NO]#K
M SV:D2&6>.<KK!W/]E!XR"^690$B/V:N_@]02P$"% ,4    " #PACU;&N:!
M_E +  "100  &0              @ $     9' R,S4P.#E?97AF:6QI;F=F
=965S+FAT;5!+!08      0 ! $<   "'"P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>dp235089_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-29</startDate>
            <endDate>2025-09-29</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-29</startDate>
            <endDate>2025-09-29</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-09-29</startDate>
            <endDate>2025-09-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">7358</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">7358000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">1126.51</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">7358000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">1126.51</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">1126.51</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">7358000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
